partner signalings by Ingenuity pathway analysis. Ten of the 26 pathways and three genes (ITSN1, UBC and HSPA5) were reported to be regulated in the above four conditions. Paired induction of Carom/ITSN1 elevation was associated with pathological angiogenesis. Whereas, paired reduction of Carom/HSPA5 or UBC was associated with iPSC generation. These results provide an insight on identifying Carom complex model and predicting its functional implications.
In the past ten years, bioinformatics analysis has become an important tool for functional interpretation of genomics and proteomics prediction. We have established several database mining strategies to determine functional relationship of genes in specific metabolic groups by using National Institutes of Health (NIH)/National Center of Biotechnology Information (NCBI) Gene database and Expression Sequence Tag (EST) database, Gene Expression Omnibus (GEO) database and Transcription Element Search System (TESS) database (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) . We also established various working models to predict and explain mechanisms underlying cardiovascular and inflammatory diseases (9, 12, 14, 16) .
However, bioinformatics analysis has not been used to analyze protein-protein interaction prediction. In this study we developed a novel database mining strategy to determine Carom complexes and signaling pathways by using the combination of multiple national database and software system, including NCBI Gene database and EST database, GEO database, Ingenuity pathway analysis (IPA) software and PubMed literature reviews. We identified Carom partners, presented a comprehensive analysis of tissue mRNA distribution profiles of Carom and partners in human and mouse tissues, analyzed conditions with altered Carom signaling and partner expression changes in various cells, and finally developed a working model of Carom protein complex in physiological and pathophysiological processes.
MATERIALS AND METHODS

Identification of Carom partners (NCBI Gene database)
As previously described, an experimental data mining strategy was used to establish tissue expression profiles of Carom and its interacting partners (16, 14, 11) (Figure 1 ). A total of 26 binding partners for Carom protein were identified by mining NCBI Gene database (http://www.ncbi.nlm.nih.gov/gene/9873) ( Table 1 ). These databases provided information for partnership determined via the following experimental approaches. (1) Two-hybrid identify the protein-protein interaction by transcription factor activation initiated by fusion of the factor's DNA binding domain and its transcriptional activation domain (19) . (2) Affinity Capture-Mass spectrometry (MS) analysis determine the interaction when a bait protein is captured by either a specific antibody or an epitope tag and the interaction partner is analyzed via mass spectrometry (20) . (3) Co-immunoprecipitation identify the interaction when a bait protein is immunoprecipitated by specific antibody and the interacting protein is also co-immunoprecipitated and identified by Western Blot (21) . (4) Affinity Capture-RNA recognize the interaction for RNA-binding proteins when a bait protein is affinity captured by either a specific antibody or an epitope tag and associated RNA species are identified by Northern blot, RT-PCR, affinity labeling, sequencing, or microarray analysis (22).
Tissue mRNA distribution profiles of Carom and partners (EST database)
A total of 21 human and 20 mouse tissues were given tissue ID numbers and examined for mRNA expression by mining human and mouse EST databases deposited in the NIH UniGene database (23) (http://www. ncbi.nlm.nih.gov/unigene). The EST database is created via cDNA cloning from various tissue cDNA libraries followed by DNA sequencing. As previously described, we used relative mRNA expression units (REU) of Carom and binding partners, normalized by the transcripts per million (TPM) of Carom and binding partners with that of β-actin (left-side y-axis). Further, we determined the median REU (mREU) of the human and mouse tissues in order to compare the gene expression. The ratio of REU/mREU was expressed as tissue median adjusted mRNA expression units and presented in Figure 3A (right-side y-axis). A confidence interval for the gene expression was generated using mean REU and 2 times the standard deviation (SD) (mean ± 2SD) of the REU of 3 randomly selected housekeeping genes (pituitary tumor-transforming 1 interacting protein (PTTG1IP), pyruvate kinase muscle (PKM2), and heterogeneous © 1996-2016 nuclear ribonucleoprotein K (HNRNPK)) in 21 human or 20 mouse tissues, normalized by β-actin in given tissues. If the expression variation of a given gene in the tissues was larger than the upper limit of the confidence interval of the housekeeping genes, the high expression levels of genes in the tissues were considered statistically significant.
Identification for conditions altering Carom expression (GEO database)
To examine the differential expression profiles of Carom in response to various experimental conditions, we searched the high-throughput functional genomics datasets in NCBI/GEO database (http://www.ncbi. nlm.nih.gov/gds). The datasets enabled us to identify the expression changes of Carom in endothelial cells (ECs), monocytes, macrophages, smooth muscle cells and epithelial cells from 19 datasets involving three experimental conditions including inflammatory, reprogramming and angiogenesis (Table 3) . If the fold changes of gene expression were ≥1.5. with P <0.0.5 in treated cells, it was considered a significant increase. Gene expression fold changes ≤ 0.8. with P <0.0.5 were considered a significant decrease.
Pathway analysis of Carom and partners (Ingenuity pathway analysis)
Carom and 26 binding partners were analyzed using Ingenuity Pathway Analysis software (Ingenuity Systems, Redwood City, CA) to predict the molecular networks and signaling pathways of Carom complex. Significance of association between sets of genes and related molecular and cellular functions was assessed using the Fisher's Exact Test. Significant Carom complex signal pathways were selected and presented in Figure 4 based on a default threshold of IPA (-log (p-value) >1.3.) meaning that P value <0.0.5.
Predicted function of Carom complex signaling (PubMed)
In order to identify the functional connection of Carom complex, we screened Pubmed information for reported Carom signaling regulation in the identified 26 pathways from IPA analysis. Four conditions were used for this screening based on GEO analysis data presented in Table 4 (hypoxia, endometrial, PPARγ depletion and iPSC reprogramming). Pubmed ID related with reported Carom complex signaling pathway regulation and changed Carom partner were presented.
RESULTS
Identification of 26 Carom partners
A total of 26 genes were identified as Carom (FCHSD2) partners from NCBI Gene database (Table 1) . The partnership was recognized by various experimental systems, including Two-hybrid, affinity Capture-MS, co-immunoprecipitation and affinity Capture-RNA. These (Fig 2) . Relative mRNA expression units and tissue expression profiles were generated using NCBI EST database (Fig 3) . Tissues were classified based on the expression of Carom/partners (Table 1 ). Inflammation and induced pluripotent stem cells (iPSC) generation were identified as conditions where Carom/partners gene expression altered in endothelial cells (ECs) by querying GEO datasets (Table 2-4). 26 signaling pathways were recognized potentially involved in Carom/partners signaling by using Ingenuity pathway analysis (IPA) software (Fig 4) . 10 of these 26 pathways were reported in Pubmed and 3 Carom complexes and its function were identified by GEO/IPA/Pubmed cross search (Table 5&6 ). A working model Carom complex in regulating angiogenesis and iPSC generation in ECs was generated (Fig 5) . Abbreviations: ECs, Endothelial cells; EST: Expressed sequence tags; GEO, Gene expression omnibus; IPA, Ingenuity pathway analysis; iPSC, induced pluripotent stem cells. © 1996-2016 Carom was initially identified as an interacting protein of membrane-associated guanylate kinase inverted 1 (MAGI1) by two-hybrid screening (24) . As shown in Figure 2 , Carom contains an N-terminal F-BAR domain, two C-terminal SH3 domains and a © 1996-2016 PSD-95/Dlg-A/ZO-1 (PDZ) binding motif. It binds to the fifth PDZ domain of MAGI1 via its PDZ binding motif. It was reported that Carom can also bind to calcium/calmodulin-dependent serine protein kinase (CASK) protein. CASK has one calmodulin kinase (CAMK) domain, one PDZ domain, one SH3 domain and one guanylate kinase (GK) domain. Carom binds to CASK via its C-terminal region. Both CASK and MAGI1 belong to membrane-associated guanylate kinases (MAGUK) family, which interact with partners to regulate cell junctions (25) . It is suggested that CASK can compete with MAGI1 to complex with Carom and is a dominant regulator for cell junction in polarized epithelial cells (24).
Carom and 26 partners are differentially expressed in human and mouse tissues
We established tissue mRNA expression profiles of Carom and 26 partners in 21 human and 20 mouse tissues by EST database mining (Figure 3 ). Confidence intervals were generated based on mRNA expression levels of 3 housekeeping genes (PTTG1IP, PKM2, and HNRNPK), which have relatively consistent mRNA levels across the selected tissues in both human and mouse.
In Figure 3A , PTTG1IP expression profiles are presented as representative of housekeeping genes. The confidence intervals of the housekeeping gene expression are X ± 2SD = 3.2.4 in human tissues and X ± 2SD = 3.3.2 12 of 26 potential Carom partners identified in Table 1 are presented with changed mRNA levels. In hypoxia conditions, Carom and MAGI1 were both induced. In endometrial ECs, Carom and ITSN1 were induced. In PPARγ deleted ECs, Carom was induced along with CASK, CHKA, ITSN1, ITSN2 and SH3BGR induction.
During the reprograming of ECs to iPSC, Carom and GRASP, HSPA5, HTRA1, ITSN2 and UBC were induced. These paired induction suggests a potential functional Carom complex in these conditions. ⊗, fold changes of mRNA in treated cells over the expression level of gene in control cells. *, Changes ≥1.5. with P<0.0.5 was considered as significant increase; Changes ≤ 0.8. with P<0.0.5 was considered as significant decrease. Abbreviations: refer to Figure 1 and Table 3 © 1996-2016 in mouse tissues, and not significantly different between species. Lines indicating an upper limit of the confidence interval were put in all bar graphs of tissue profiles to establish the significance of gene expression. mRNA expression levels of Carom and partners higher than the upper limit of the confidence interval of housekeeping genes were considered statistically significant higher expression in tissues.
In human tissues, Carom is highly expressed in the lymph node, pituitary gland and nerves in human tissues ( Figure 3B ). According to the tissue expression profiles of Carom and 26 partners, the 21 human tissues can be classified into three tiers (Table 2A) . Tier 1 tissues are "Ready to go" tissue, which expresses Carom and some of the partner genes. Human lymph node, pituitary gland and nerve belong to this Tier 1 category. Tier 2 tissues are "Nearly ready" which express Carom partner genes but lack of Carom, including heart, lung, vascular, brain, pancreas, liver, blood, bone marrow, spleen and others as detailed in the table. Tier 3 tissues are "Function privilege" and lack both Carom and partner gene expression, and are only identified in mouse but not in human.
In mouse tissues, Carom is highly expressed in blood, eye, lymph node, spleen and ovary in mouse tissues ( Figure 3C ). The expression patterns of Carom and 26 partners can also be classified into three tiers (Table 2B ). Tier 1 "Ready to go" tissues include blood, eye, lymph node, ovary and spleen. Tier 2 "Nearly ready" tissues include brain, heart, and pancreas. Tier 3 "Function privilege" tissues include bone, connective tissue, embryonic tissue, kidney, liver and lung.
Inflammatory and reprogramming conditions altered Carom expression
As indicated in Table 3 , via GEO database mining, Carom mRNA levels were found increased by 3.8. fold and 1.6. fold in hypoxia treated mouse pulmonary endothelial cells (ECs) (GDS ID# 61) and in human endometrial ECs (GDS ID# 3060). It was reduced by 0.5. and 0.2. fold in PPARγ deleted mouse aortic ECs (GDS ID# 3440) and during the reprogramming of human placental ECs to iPSC by co-infection of retroviral (pMXs)-OCT3/4, SOX2, KLF4 and c-MYC (GDS ID# 3842). Carom expression levels were not changed in angiogenesis conditions in ECs, nor in monocytes, macrophages, smooth muscle cells and epithelial cells treated with various conditions.
Paired Carom partners in inflammatory and reprogramming conditions
We found that Carom was altered in inflammatory and reprogramming conditions, including hypoxia, endometrial, PPARγ depletion and iPSC reprogramming (Table 3) . We suspected that Carom complex participates in these processes and continued to examine their potential partners. As shown in Table 4A , we identified 12 partners having paired changes with Carom suggesting these partner proteins may have a paired increasing or decreasing complex relationship with Carom. Carom and MAGI1 were both regulated in hypoxia treated ECs. We identified paired induction of ITSN1 with Carom in endometrial ECs. In contrast, Carom was reduced in PPARγ deleted ECs, which was paired with CASK, CHKA, ITSN1, ITSN2 and SH3BGR reduction. During iPSC reprogramming, Carom was reduced along with GRASP, HSPA5, HTRA1, ITSN2 and UBC reduction (Table 4B ).
Carom complex pathway analysis
We identified 26 signaling pathways, which involve the expression changes of Carom partner proteins using IPA software. These pathways have a high threshold determined by publication frequencies. The Protein ubiquitination pathway, which involves Carom complex proteins UBD, UBC, HSP90AB1, HSPA5, was most frequently reported and has the highest -log (P value), followed by adherent junction signaling, ephrin receptor signaling and others as detailed in Figure 4 . We further screened for reported Carom signaling regulation in these pathways in above four conditions by GEO analysis (Table 4) and Pubmed literature search.
We presented the Pubmed ID related with reported Carom complex signaling pathway regulation and altered Carom partner in Table 5 . We found 10 pathways characterized in hypoxia, endometriosis, PPARγ deletion and iPSC generation conditions. Ephrin receptor signaling, clathrin-mediated endocytosis signaling, eNOS signaling, integrin signaling and actin cytoskeleton signaling were changed in hypoxia treated ECs (PMID ID#: 19834031, 23861904, 24938229, 22353471 and 24144209). UBC change was associated with altered clathrin-mediated endocytosis and wnt/β-catenin signaling in iPSC generation. HSPA5 change was associated with altered endoplasmic reticulum stress in iPSC generation. ITSN1 change was associated with altered axonal guidance signaling in endometrial ECs.
As summarized in Table 6 , paired Carom (1.6.-fold) and ITSN1 (1.7.-fold) induction is associated with enhanced axonal guidance signaling and angiogenesis phenotype in endometrial ECs. During iPSC reprogramming, paired Carom (0.2.-fold) and HSPA5 (0.3.-fold) reduction is associated with increased endoplasmic reticulum stress; Paired Carom (0.2.-fold) and UBC (0.8.-fold) reduction is associated with decreased clathrin-mediated endocytosis and increased wnt/β-catenin signaling.
DISCUSSION
In this study, we employed a group of combined database mining strategies and reported five major findings: (1) 
Carom and partner proteins are differentially expressed in tissues
We presented in Figure 3 , that Carom is differentially expressed in human and mouse tissues.
Each tissue has different expression pattern for Carom and partner proteins. This data suggests that Carom signaling can be differentially regulated and that the readiness of Carom signaling varies in individual tissues. We classified the analyzed 21 human tissues and 20 mouse tissues into three tiers (Table 2) . We anticipate that Carom complex signaling is essential in Tier 1 "ready to go" tissue, in which Carom signal is essential and its expression including the partners is ready in normal condition. The Tier 2 tissues require the induction of Carom as it contains only the complementary partners but lack of Carom. It may take longer time to overcome Table 3 were analyzed by Pubmed literature search and GEO database mining (Table 4) . Altered Carom signaling are described in manuscript cited by Pubmed ID. Carom partner proteins involved in these signaling are bolded and indicated in the table following Pubmed ID. Abbreviations: refer to Figure 1 and Table 2 -4 © 1996-2016 a threshold in Tier 2 tissues than in the Tier 1 tissues to activate Carom complex signaling. Because neither Carom, nor its partners are expressed in Tier 3 tissues in human, suggesting that Carom systems may not be required in these tissues in human.
It is noticed that some tissues are classified differently in human and mice, except for lymph node. We found that lymph node is the only Tier 1 tissue in both human and mouse, suggesting that Carom complex signaling may be equally essential in both human and mouse for immunological processes. By using GEO database mining, there is limited information of Carom in lymph node. Recently, the development of lymph node has been reported to be dependent on EC-restricted lymphotoxin-β receptor signaling (26). Thus, it is possible that Carom complex initiates signaling pathways in ECs to regulate the development of lymph node. Interestingly, pituitary gland is a Tier 1 tissue in humans but not in mice. It is likely that Carom signaling is more important in humans than in mice for development and hormone production control. Apparently, most of the human tissue are Tier 2 tissues, including blood, eye, ovary and spleen. Carom signaling regulation may be sensitive in most of the human tissues to initiate its downstream functions.
It is worth pointing out that tissue expression profile was determined by database mining approach utilizing the NCBI Gene database and EST database in which mRNA levels were calculated based on the copy number of EST cDNA clone sequencing, as we discussed previously (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) . We believe that the EST database is reliable for gene mRNA expression in normal tissues and has significant advantages over traditional approaches, such as Northern blots and RT-PCR analysis. Therefore, the expression patterns of Carom and 26 partners are experimentally based and precise.
Expression of Carom complex is altered in inflammatory and reprogramming conditions
Via GEO database, we identified 12 partner proteins having paired changes with Carom in four different conditions (hypoxia, endometriosis, PPARγ deletion and iPSC reprogramming) treated ECs (Table 3&4 ). Hypoxia and PPARγ deletion induce inflammatory injuries in ECs, while endometriosis presents with high level of pro-inflammatory cytokines for stimulating ECs (27) (28) (29) . Accordingly, hypoxia, endometriosis, PPARγ deletion were classified into inflammatory condition. We believe that Carom complex signaling may be regulated and mediate some functional changes in inflammatory and iPSC reprogramming conditions. Among the inflammatory condition, Carom-MAGI1 pair was induced by hypoxia in ECs and Carom-ITSN1 pair was induced in endometrial ECs. Because hypoxia can induce angiogenesis in ECs via increasing expression of VEGF receptor (30) and endometriosis is an angiogenesis pathology by enhancing secretion of VEGF in endometriotic lesion (31) , induced Carom signal may be relevant to pathological angiogenesis. Although Carom expression levels are not changed in angiogenesis conditions in ECs on GEO database mining results, it is possible that Carom is associated with pathological angiogenesis in disease. The pathological connection of Carom-CASK, Carom-CHKA, Carom-ITSN1, Carom-ITSN2 and Carom-SH3BGR pair reduction in PPARγ deleted ECs remains unclear and needs to be established in future studies. It is possible that Carom signaling can prevent iPSC reprogramming as a reduced Carom-signaling may be involved in iPSC reprogramming as Carom-GRASP, Carom-HSPA5, Carom-HTRA1, Carom-ITSN2 and Carom-UBC were reduced in these conditions. These partner proteins may have increased or decreased complex relationship with Carom, and may mediate Functional implications of Carom complex is evaluated based on identified paired Carom & partner changes (Table 4) The GEO database is relatively newer than the EST database. It contains high-throughput experimental data from functional research assessing conditional gene expression changes (32) . It is a powerful tool to search the functional connection of novel proteins. Experimental conditions employed in the GEO database provide relevant pathophysiological connections for novel genes with limited functional research evidence.
Carom signal pathway, function and working model
Using IPA pathway analysis, we identified 26 Carom complex signal pathways based on Carom partner expression changes reported in the Pubmed and national databases (Figure 4) . The combinatory analysis of pathway identification and experimentally confirmed Carom pair changes led us to propose a working model of Carom signaling in Figure 5 . We hypothesize that Carom-ITSN1 complex activation may mediate pathological angiogenesis and that Carom-HSPA5 and Carom-UBC complex suppression may prevent iPSC generation.
Carom-ITSN1 complex activation and angiogenesis
We found a paired induction of Carom-ITSN1 in endometrial ECs, which is associated with enhanced axonal guidance signaling and angiogenesis phenotype. Endometriosis is a neurovascular disorder characterized by ectopic growth of endometrial lesion outside the uterus (33) along with enriched nerve bundles and blood vessels. We hypothesize that Carom-ITSN1 pair induction may regulate pathological angiogenesis in endometriosis. As indicated in Figure 4 via IPA analysis, ITSN1 was involved in the regulation of axonal guidance signaling. It is reported that ITSN1 encodes Intersectin-1 protein which regulates synaptic vesicle recycling and induces axonal guidance signaling during the development of nervous system in mouse (34) . Axonal guidance molecule is reported to promote angiogenesis and suppress neurogenesis in neurons which are complementary effects in endometriosis lesions (35) . Therefore, we propose that Carom-ITSN1 complex induction could promote pathological angiogenesis in endometriosis via activation of axonal guidance signaling.
Carom-HSPA5 and Carom-UBC complex suppression and iPSC generation
We identified a paired reduction of Carom-HSPA5 associated with enhanced endoplasmic reticulum stress and Carom-UBC associated with clathrin-mediated endocytosis inhibition and wnt/β-catenin signaling activation during iPSC generation.
HSPA5 encodes the protein Heat shock protein A5, which is a resident protein in the lumen of the endoplasmic reticulum. As indicated in Figure 4 , Figure 5 . Working model of Carom complex-angiogenesis/iPSC generation in EC. In endometriosis condition, Carom can bind to ITSN1 to activate axonal guidance signaling, leading to pathological angiogenesis. Carom can be induced in hypoxia condition to form complex with MAGI1 and be suppressed in PPARγ deletion condition to weaken the complex with CASK, CHKA, ITSN1, ITSN2, SH3BGR. In iPSC reprograming condition, Carom can also be reduced to inhibit the formation of complex with HSPA5 and UBC, which leads to endoplasmic reticulum stress and wnt/β-catenin signal activation, and reduces clathrin-mediated endocytosis. Carom complex suppression results in iPSC generation. Solid lines represent final working model concluded in this work. Dashed lines represent predicated complex via GEO database analysis (Table 4) . © 1996-2016 HSPA5 is involved in the regulation of endoplasmic reticulum stress. Endoplasmic reticulum stress has been reported to facilitate iPSC generation via inducing vascular endothelial growth factor (VEGF) (36) . Thus, we hypothesize that Carom-HSPA5 suppression may promote iPSC generation via activation of endoplasmic reticulum stress. It would be interesting to investigate Carom-HSPA5 complex regulation and VEGF secretion, and its relevance with iPSC generation.
UBC represents an ubiquitin gene and encodes polyubiquitin-C protein, which is involved in the regulation of clathrin-mediated endocytosis and wnt/β-catenin signaling (Figure 4) . Clathrin-mediated endocytosis regulates signal transduction, nutrient uptake and neurotransmission at the cell membrane (37) . In clathrinmediated endocytosis, F-BAR protein complexes are essential in regulating the formation of clathrin-coated vesicles (2, 38) . It has been shown that transforming growth factor-β (TGF-β) acts as a barrier to iPSC generation via inhibition of mesenchymal-epithelial transition (39, 40) . Clathrin-mediated endocytosis can positively regulate TGF-β signaling by recycling TGF-β receptors (41) . During iPSC generation, clathrin-specific inhibitor Pitstop2 inhibits TGF-β signaling (42) . In the presence of TGF-β inhibitor SB431542, Pitstop2 can not suppress TGF-β signaling or increase iPSC generation. Therefore clathrin-mediated endocytosis is also identified as a barrier of reprogramming iPSC via activation of TGF-β signaling. We identify a suppressed Carom-UBC complex during the generation of iPSC which is associated with clathrin-mediated endocytosis signaling. Thus, Carom-UBC suppression may inhibit clathrinmediated endocytosis and attenuate its barrier function in promoting iPSC generation.
We propose another possible mechanism for Carom-UBC complex induced iPSC generation based on the connection of UBC and wnt/β-catenin signaling we identified via IPA analysis (Figure 4) . One possibility is that Carom-UBC complex signaling may contribute to iPSC generation via wnt/β-catenin induced c-Myc, as c-Myc is a well-established target of wnt/β-catenin pathway (43) and a key inducer of iPSC reprogramming. However, it is also possible that wnt/β-catenin signaling may promote iPSC generation independent from c-Myc as it was found that wnt/β-catenin signaling can promote iPSC generation in the absence of c-Myc retrovirus (44) . We anticipate that Carom-UBC complex reduction may promote iPSC generation via activating wnt/β-catenin signaling.
CONCLUSIONS
In this study, we identified 26 Carom partners and characterized their tissue expression profiles. We found that Carom complex signaling can be induced by inflammatory and iPSC conditions and predicted 26 potential Carom signal pathways. We propose three Carom complex working models. 1) Carom-ISTN1 complex induction promotes pathological angiogenesis. 2) Carom-HSPA5 and Carom-UBC complexes suppress iPSC generation. Our combined database mining strategy is an important advance in merging EST database, GEO datasbase, IPA signal analysis and PubMed literature reviews to identify protein complex working model. This strategy could predict the functional implications and signal pathways of a novel protein complex. The predicted results provide hints and direction for future studies to investigate the role and mechanism of novel protein complex in pathophysiological process of animal models and human diseases.
